Montco biopharm firm begins human studies of iron overload therapy

Trial of ‪‎Merganser‬'s beta ‪‎thalassemia‬ ‪‎drug‬ candidate begins a ‪‎clinical‬ ‪‎trial‬ is underway to evaluate Merganser Biotech's M012, which is being developed as a treatment candidate for conditions such as beta thalassemia and some subtypes of myelodysplasia.